Page last updated: 2024-09-03

annamycin and idarubicin

annamycin has been researched along with idarubicin in 1 studies

Compound Research Comparison

Studies (annamycin)	Trials (annamycin)	Recent Studies (post-2010) (annamycin)	Studies (idarubicin)	Trials (idarubicin)	Recent Studies (post-2010) (idarubicin)
29	3	1	1,795	454	487

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andreeff, M; Consoli, U; Griffin, M; Ling, YH; Mahadevia, R; Perez-Soler, R; Priebe, W; Zhao, S	1

Other Studies

1 other study(ies) available for annamycin and idarubicin

Article	Year
The novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines. Blood, 1996, Jul-15, Volume: 88, Issue:2 Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; HL-60 Cells; Humans; Idarubicin; Molecular Structure; Neoplasm Proteins; Structure-Activity Relationship; Verapamil	1996

Article

Year

The novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines.

Blood, 1996, Jul-15, Volume: 88, Issue:2

Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; HL-60 Cells; Humans; Idarubicin; Molecular Structure; Neoplasm Proteins; Structure-Activity Relationship; Verapamil

1996